Sandeep Agrawal

1) Delta Corp on hope of re-opening of Casinos in Goa after media reports that the Maharashtra government has allowed to re-open bars, restaurants from the first week of Oct. Delta gained 5% to Rs113 amid 10lakh shares trade on NSE. Traders short term buying opportunity on Delta. 2) Defence Minister Rajnath Singh on Monday chaired the Defence Acquisition Council (DAC) meeting and approved proposals for capital acquisition of various equipment required by the Indian Armed Forces at an approximate cost of Rs 2,290 crore. These include procurement from the Domestic Industry as well as Foreign vendors. Expect positive HAL, BDL, BEL #MOMarketUpdates #MotilalOswal #Delta #indianstockmarket #Nifty #Sensex #defensestocks

1) The increasing dependency on tech due to the pandemic is resulting in better performance of IT stocks. The positive result of Accenture also resulted in fresh buying of tech stocks in Indian market. 2) Vodafone has won arbitration against India over the government's retro tax demand of Rs 20,000 crore at the Permanent Court of Arbitration in Hague on Friday. The Hague Court in its ruling said that the conduct of the Indian tax department is in breach of "fair and equitable" treatment. The Arbitration Tribunal has directed the Indian Tax Department to cease the conduct on the question. A failure to comply will engage its international responsibility. #MOMarketUpdates #MotilalOswal #Vodafone #ITstocks #Indianstockmarket #stockrecommendation #investingtips #NSE #BSE

1) Apollo Hospitals witnessed smart rally although Sensex nosedived over 1000 points. Good quarterly results and traders focus on the defensive stock in the volatile market lifted Apollo Hospital.2) Maruti Suzuki Subscribe allows a customer to use a new car without actually owning it and by paying an all-inclusive monthly fee that comprehensively covers complete maintenance, insurance and roadside assistance," it said. Customers can select subscription duration ranging from 12 months to 48 months and pay a monthly subscription charge starting Rs 14,463 (including taxes) for Swift Lxi in Delhi for a tenure of 48 months. After the completion of subscription tenure, the customer can also opt to upgrade the vehicle, extend, or buy the car at market price. Last month the project was launched as a pilot in Hyderabad & Pune. #MOMarketUpdates #MotilalOswal #Indianstockmarket #BSE #NSE #MarutiSuzuki #ApolloHospitals #Sensex #Nifty

1) ICRA assigns stable outlook to bank facilities and NCDs of Jindal Steel. The stock jumped 4%.2) Hexaware says that the promoter HT Global Holdings has accepted the discovered price of Rs 475 per share, as the final price for the delisting offer. The promoter will acquire 8.72 crore shares, post the acquisition, promoter shareholding in the company will be 91.16%. #MOMarkrtUpdates #MotilalOswal #indianstockmarket #nifty #sensex #jindalsteel #hexaware

As the world highly depends on technology during Covid-19, the technology stocks the IT stocks are gaining attention. HCL has hit a 52-week new high. #MOMarketUpdates #MotilalOswal #ITstocks #indianstockmarket #stockrecommendation #HCL #TCS

HAAH Automotive Holdings Inc., a US automobile distributor, has offered to invest 300 billion won ($258 million) in Ssangyong Motor Co. as part of its bid to take a significant stake in the South Korean automaker, according to sources in the investment banking industry. Expect positive for M&M. #MOMarketUpdates #MotilalOswal #IndianStockMarket #NSE #BSE #Mahindra

The Pharma stocks are positive due to multiple approvals of US FDA for different medicines. The companies are also manufacturing the drugs for the primary treatment of Covid-19. Dr Reddy's Laboratories reclaimed the tag of being the second most valuable listed pharmaceutical company. Sun Pharma is the most valued listed company of India with the market cap of Rs 1.26lakh cr. With a favourable ruling in the appeals court, the odds of launching gVascepa also rise considerably. Bristol Myers Squibb had inked a patent settlement with Dr. Reddy’s Laboratories, allowing the Indian generics company to start with a “volume-limited” launch sometime after March 2022. The exact date of the rollout, and amount of generic Revlimid Dr. Reddy’s will be allowed to sell, are confidential. But on January 31, 2026, the company will have a license to sell its generic Revlimid with no limits. #MOMarketUpdates #IndianStockMarket #MotilalOswal #NiftyPharma #NSE #BSE #Recommendation #Stocktip #Stockrecommendation

1) Happiest Minds Technologies Ltd. debuted on the bourses at a 115% premium to its issue price AT Rs166 a share, a week after concluding its initial public offering on a remarkable note. The Rs 702-crore maiden offer was subscribed 151 times. It has gained 125% to close at Rs371 against its IPO price amid 52cr shares traded on NSE.2) Domestic Pharma major Dr Reddy closed at an all-time high of Rs4827 after the news that the Russia-based Russian Direct Investment Fund (RDIF) to distribute 10cr Covid-19 vaccine doses in India. Moreover, the Company launched Eye Allergy drop in US Market.3) SBI - The country’s largest lender State Bank of India could be sitting on a goldmine when it comes to its digital start up YONO (You only need one). The super-app could be valued at $40 billion with the lender considering long term plans to hive it off as a separate entity once it assumes a specific size- says SBI Chairman. #MOMarketUpdates #MotilalOswal #IndianStockMarket #NSE #BSE #Nifty #sensex #IPO #Pharma #SBIYONO

Russia’s RDIF to sell 100m doses of Covid-19 vaccine to India. Russian sovereign wealth fund to cooperate with India’s Dr. Reddy’s Laboratories on clinical trials and distribution of Sputnik V vaccine against coronavirus, Russian Direct Investment Fund says in a statement. RDIF to also sell as many as 50m doses to Brazil, 32m to Mexico. #MOMarketUpdates #MotilalOswal #DrReddys #Indianstockmarket #marketrecommendation #NSE #BSE #nifty #sensex